HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior.

Abstract
The aim of the study was to elucidate the significance of claudins in surgically treated esophageal carcinoma. The expression of claudins 1, 3, 4, 5 and 7 was studied by immunohistochemistry. Tumor proliferation was assessed with Ki67 immunostaining and apoptosis by the TUNEL method and immunostaining of fragmented caspase 3. Adenocarcinomas showed significantly more cases with moderate or strong claudin 3 (p<0.001) and claudin 5 positivity (p=0.031) compared to squamous cell carcinomas. Loss of claudin 3 expression was associated with the presence of distant metastases (p=0.039). Claudins 3, 4 and 7 had a significant association with either a high apoptotic index or a high number of caspase 3-positive cells, while claudin 5 was associated with increased proliferation. In esophageal carcinoma, claudin expression may vary along with the histology of the tumor. Claudin expression may also be associated with apoptosis or proliferation, suggesting that claudins may contribute to tumor behavior and growth.
AuthorsH Takala, J Saarnio, H Wiik, Y Soini
JournalAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica (APMIS) Vol. 115 Issue 7 Pg. 838-47 (Jul 2007) ISSN: 0903-4641 [Print] Denmark
PMID17614851 (Publication Type: Journal Article)
Chemical References
  • CLDN1 protein, human
  • CLDN3 protein, human
  • CLDN4 protein, human
  • CLDN5 protein, human
  • CLDN7 protein, human
  • Claudin-1
  • Claudin-3
  • Claudin-4
  • Claudin-5
  • Claudins
  • Membrane Proteins
Topics
  • Apoptosis
  • Carcinoma (metabolism, secondary)
  • Cell Proliferation
  • Claudin-1
  • Claudin-3
  • Claudin-4
  • Claudin-5
  • Claudins
  • Esophageal Neoplasms (metabolism, pathology)
  • Female
  • Humans
  • Male
  • Membrane Proteins (analysis, deficiency, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: